Sandbox W00
From Proteopedia
(Difference between revisions)
(2 intermediate revisions not shown.) | |||
Line 5: | Line 5: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
+ | |||
+ | <quiz display=simple> | ||
+ | { | ||
+ | |type="{}"} | ||
+ | Name a famous Greek philosopher. | ||
+ | { Aristotle|Plato } | ||
+ | |||
+ | {Question | ||
+ | |type="[]"} | ||
+ | + Correct answer. | ||
+ | - Incorrect answer. | ||
+ | + Correct answer. | ||
+ | - Incorrect answer. | ||
+ | </quiz> | ||
Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'>PMID 8415649</ref><ref>pmid 12345</ref> | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'>PMID 8415649</ref><ref>pmid 12345</ref> | ||
Line 24: | Line 38: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 33: | Line 47: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 42: | Line 56: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 51: | Line 65: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 60: | Line 74: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 69: | Line 83: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 78: | Line 92: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 87: | Line 101: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 96: | Line 110: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | ||
Line 105: | Line 119: | ||
Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | Tacrine is a reversible inhibitor of cholinesterase. It was the first FDA approved drug for the treatment of Alzheimer's disease. | ||
- | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). | + | Tacrine’s ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330). <ref name='harel'/> |
<scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> | <scene name='70/703975/Mytacrine/1'>TextToBeDisplayed</scene> |
Current revision
Your Heading Here (maybe something like 'Structure')
|
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9031-5. PMID:8415649
- ↑ Rubinstein MH. A new granulation method for compressed tablets [proceedings]. J Pharm Pharmacol. 1976 Dec;28 Suppl:67P. PMID:12345